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ABSTRACT
Telomeres are the sequences of nucleotides at the end of chromosomes. Each time a cell
divides, telomeres become shorter. The length of telomeres can be replenished by an
enzyme, telomerase. Telomere shortening is hypothesized as the biological origin of aging.
Indeed, telomeres are shorter in people with various diseases than others. Whether these
observed associations are causal or due to other factors that could be the common causes
of both telomere shortening and diseases are largely unknown. In this thesis, we aimed to
disentangle the relationship between telomere length and several aging-associated diseases
and traits to enhance our understanding of the biology underpinning disease pathogenesis.
In Study I, we performed a Mendelian randomization (MR) study examining the
association between telomere length and Alzheimer’s disease, using genome-wide associ-
ation study (GWAS) summary statistics data released by the International Genomics of
Alzheimer’s Project Consortium. We used seven single-nucleotide polymorphisms (SNPs)
identified to be of genome-wide significance for telomere length as instrumental variables.
The MR analysis showed that shorter telomere length was associated with higher odds of
Alzheimer’s disease.
In Study II, we explored the potential pathways from telomere length to coronary heart
disease using network MR method. The same seven SNPs were used as instrumental
variables as in Study I. Various GWAS summary statistics data of metabolic biomarkers
and coronary heart disease were used. The MR analyses found that shorter telomeres were
associated with higher levels of insulin, which also had an effect on coronary heart disease.
Overall, this study indicates that insulin lies in the pathway from shorter telomeres to
coronary heart disease.
In Study III, we investigated the association of telomere length with trajectories of
general cognitive abilities in two Swedish cohorts (SATSA and GENDER) and two US
cohorts (MCSA and HRS). Telomere length was measured once, while general cognitive
abilities were assessed repeatedly at up to seven occasions. Latent growth curve models
were applied to examine the associations. We found that shorter telomere length was
associated with lower mean levels of general cognitive ability in the age-adjusted models,
but not in models when other covariates were further considered. We did not find evidence
to support that telomere length was associated with the decline of general cognitive ability.
In Study IV, we revisited the association of telomere length with all-cause mortality,
allowing for time-varying effects in a Swedish twin sample where shared familial confound-
ing could be controlled for. Telomere length was measured using Southern blot method,
and data of all-cause mortality was obtained from the Swedish Population Registry. We
applied between-within analyses in a shared-frailty generalized survival model framework.
We found that shorter telomere length was associated with higher mortality rate when
controlling for shared familial confounding. Further, we found significant time-varying
effects of telomere length on mortality.
In summary, we presented novel evidence about the role of shorter telomere length in
aging related diseases and traits in this thesis. We took advantage of publicly available
GWAS summary statistics data as well as individual-level cohort data and used various
innovative designs and statistical methods to achieve this. This compiled thesis could
contribute substantially to the literature of the short and long story of telomeres.
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1. Background
Telomeres are repetitive sequence of nucleotides at the end of chromosomes. By protecting
the end of chromosomes, they have been recognized as the fundamental aspects of cell
biology, especially since the awarding of 2009 Nobel Prize in Physiology and Medicine
to Drs. Elizabeth H. Blackburn, Carol W. Greider, and Jack W. Szostak. As an indicator
of cellular senescence, the length of telomeres have been postulated as a biomarker of
aging in human beings. Although experimental studies have successfully shown that
telomere shortening causes cell death or some disorders, results from animal studies do not
necessarily translate to or apply to humans. Epidemiological studies play a central role in
disentangling the potential influence of telomere shortening or elongation in human health.
The causes and consequences of telomere shortening have triggered scientists’ curiosity
for decades.
The general definition of epidemiology, as a discipline of science, centers on studying
the distribution of diseases and associated causal risk factors, diagnosis and prognosis, and
treatment evaluation, etc. Modern epidemiological applications, however, span far beyond
that. In the aging epidemiology research field, people have shown persistent and increasing
interest in the causes of longevity and other chronic diseases and in how to extend life span
or to treat aging diseases. Many epidemiological techniques are potentially available for
this purpose. For instance, randomized controlled trials are the gold standard to evaluate
the effectiveness of a treatment. However, most epidemiological studies use observational
data for inference. Empirical evidence is essential, even before initiating a trial.
In this thesis, we take advantage of the modern epidemiological methods and apply
them to the publicly available data and our in-house data to examine the potential role
of telomere length (TL) in human health. We provide updated epidemiological evidence
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of the relationship of TL with coronary heart disease(CHD), general cognitive ability,
Alzheimer’s disease(AD), and all-cause mortality.
1.1 Telomere Biology
Human telomeres consist of a tract of tandemly repeated short DNA repeats, TTAGGG,
and associated protective proteins. Telomeres function as preventing the end of the
chromosomal DNA from being fused with other chromosomes that would lead to an
unstable genome. Each time a cell divides, telomeres become shorter. This telomere
attrition can be replenished by an enzyme, telomerase, that adds telomeric repeat sequences
to the ends of chromosomes, hence elongating them to compensate for their loss [1].
Length of telomeres varies across sex, age, and ethnicity. In newborns of different ethnicity,
the lengths of leukocyte telomeres were around 9.4 − 11k base pairs [2, 3]. A previous
study observed that TL in nine years old African American boys ranged from 5.0 − 22.5k
base pairs [4]. Women usually have longer telomeres than men [5, 6], and middle aged US
adults who self-identified their ethnicity as Black may have longer telomeres than those
who self-identified as White [7].
1.2 Measurement of Telomere Length
To date, several methods have been available to measure the length of telomeres. For
epidemiological studies with large sample sizes, a fast and reliable technique to assess
biomarkers has always been a challenge. Telomeres measurement is not an exception.
Besides the measuring techniques, what kind of tissue should be measured is also a concern.
Blood samples are convenient tissues that are commonly collected in most of the cohort
studies and can yield a high quality DNA that is available for telomere assays. Other
tissues, such as saliva, have also been used for telomeres assessment in epidemiological
studies. Previous studies found that TL in blood (leukocytes) has a moderate correlation
with that in other tissues [8]. Due to the vast availability of samples, blood leukocyte TL
has been generally measured and considered as a biomarker for the overall TL.
Telomere restriction fragment analysis using Southern blot was the first method used
to determine the length of telomeres. It measures the absolute length (in base pairs) for
specific samples and is a reference for other methods developed afterward [9]. This
method requires a relatively large amount of DNA, but has a simple design that does not
require specific equipment in a regular laboratory.
Quantitative polymerase chain reaction (PCR) has been developed to assess the length
of telomeres in high throughout laboratories [10]. It is fast and requires less DNA than
Southern blot; it is also the dominant method in epidemiological studies. Although it is
simple and time-saving, it cannot give absolute values of the length of telomeres unless
a prediction equation is developed with Southern blot performed on the same sample
simultaneously. Thus, it is difficult to compare the results across studies or laboratories
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using PCR method. Debate on this continuous. A modified PCR has been developed to
measure the absolute length of telomeres [11].
Other techniques to examine telomere length include quantitative-fluorescence in situ
hybridization (Q-FISH), fluorescence in situ hybridization and flow cytometry (Flow-
FISH), single telomere length analysis (STELA), etc [12, 13]. Q-FISH estimates the cell
average length of telomeres and chromosome specific length of telomeres. Flow-FISH
measures cell specific length. STELA measures single chromosome end-specific length.
More and more methods are being developed now.
1.3 Heritability of Telomere Length
Several studies to date have reported the heritability of TL using twin or family designs. The
recent Long Life Family Study with 3037 individuals shows the heritability was 0.54 [14],
while an international collaboration study found that heritability of leukocyte TL ranged
from 0.62 to 0.8 in different study populations [15]. In Sweden, our group previously
showed that TL heritability was 0.56 using data from the Swedish Twin Registry [16].
Different study populations with various age distributions might explain the inconsistent
estimates. A Danish study found that the estimated heritability of telomere length declined
with increasing age [17].
1.3.1 Genetic Factors Associated with Telomere Length
The first Genome-wide Association Study (GWAS) for TL conducted in 2009 suggested
that two variants on chromosome 18q12.2 in the same region V PS34/PIKC3C may influ-
ence telomere length, although they did not reach genome-wide significance level [18].
Later, another GWAS with a larger sample size found a variant to be of genome-wide
significance in the region of T ERC, which encodes the telomerase RNA component, and
each copy of the minor allele of rs12696304 was associated with 75 base-pair reduction in
mean telomere length [19]. A much larger study also confirmed a variant in T ERC locus,
and additionally discovered a variant in OBFC1 as a locus involved in human leukocyte
telomere biology [20]. T ERC was also confirmed in another study, but OBFC1 was not
replicated [21]. Later, a collaboration study involving more than 10 000 study participants
found two additional loci near CTC1 and ZNF676 in the general population.
The largest GWAS till now was the ENGAGE Telomere Consortium with 47 000
individuals, and it reported seven SNPs reached genome-wide significance in the close
vicinity to : TERC, TERT, NAF1, OBFC1, RTEL1, ZNF208, and ACY P2 [22]. These
findings were replicated in the COGS project, which also revealed a novel variant close
to PXK and evidence for TL loci at ZNF31 and BCL2L1 [23]. As far as I am aware of,
another two on-going GWAS investigations (GERA Study and UK biobank) with more
individuals will probably find more loci and shed light on telomere biology in the near
future.
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1.3.2 Environmental Factors associated with Telomere Length
Smoking is a major contributor to adverse health outcomes, and thus has been hypothesized
as one of the risk factors of TL attrition as well. Many studies have been conducted to
examine this association. In the Nurses’ Health Study (NHS), no association between TL
and smoking was observed [24], while another study found daily smokers had shorter
telomeres than never-smokers [25], which is similar to the findings from the Prevention
of Renal and Vascular End-stage Disease Study in the Netherlands [26]. In contrast, the
magnitude of the association was much weaker in a German cohort [27], and a longitudinal
Danish cohort did not find significant associations [28].
Alcohol consumption has exhibited a U-shaped relationship with regards to some
health outcomes. However, such a relationship has not been clearly observed in terms
of its association with TL. Although some studies suggest that alcohol consumption was
associated with shorter telomeres [29], a cross-sectional study involving 477 individuals
observed no significant association between alcohol consumption and TL [25], nor in a
Danish cohort [28]. However, studies on alcohol and telomeres are remarkably fewer than
smoking; more studies are needed.
Physical activity is always an interesting modifiable factor that deserves investigation
in relation to human health. In the Nurses’ Health Study (NHS), no association between
TL and physical activity was observed [24]. Vigorous physical activity was associated
with longer telomeres [25], which was also reported in Berlin Aging Study II that regular
physical activity for at least 10 years is necessary to achieve a sustained effect on TL [30].
However, the finding was not significant in a larger sample of Danish population [28].
The Multi-Ethnic Study of Atherosclerosis found no significant association between
energy intake and TL [31], similar to those findings in the Nurses’ Health Study (NHS)
[24]. However, a longitudinal study found more energy intake to be associated with
decreased telomeres in Israel [32]. A positive correlation between dietary total antioxidant
capacity and telomeres was found, while higher white bread consumption was associated
with shorter telomeres in fully-adjusted models in a Spanish cohort [33]. A Chinese
study found tea consumption to be associated with longer telomeres. Dietary fiber intake,
specifically cereal fiber intake, was positively associated with telomeres [34].
A recent randomized controlled trial reported that supplementation of n-3 fatty acid can
elongate leukocyte telomere length in patients with chronic kidney disease in Australia [35].
In a cohort of patients with coronary artery disease, there was an inverse relationship
between baseline blood levels of marine omega-3 fatty acids and the rate of telomeres
shortening over 5 years [36]. The effect of omega-3 fatty acids on telomere was further
confirmed in a randomized controlled trial [37]. Additionally, a significant association
between vitamin D and telomeres was observed in US [38]. In the Nurses’ Health Study,
greater adherence to the Mediterranean diet was associated with longer telomere length [39].
This finding was also reported in a multi-ethnic study, but limited to non-Hispanic whites
[40]. A comprehensive review on nutrition and TL can be found elsewhere [41].
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The Whitehall II cohort study found a linear association between shorter sleep duration
and shorter leukocyte telomeres in men but not in women [42]. But in the Nurses’ Health
Study, shorter sleep duration was associated with decreased telomeres [43]. Likewise, in a
cohort of HIV adults, similar results were obtained that longer sleep at night may either
protect telomeres from damage or restore them on a nightly basis [44]. Sleep quality was
also reported to associate with shorter telomeres [45], and sleep apnea was found to have
similar effect on telomere length [46]. However, another study in an elderly population
found insomnia to be associated with shorter leukocyte telomeres in adults aged 70-88
years old, but not in those younger than 70 years [47].
1.4 Telomere Length and Common Diseases
1.4.1 Cardiometabolic Disorders
Compared with risk factors, the associated outcomes of long and short telomeres are
more interesting to researchers and the public. Literatures on the association of TL with
metabolic disorders including coronary heart disease, diabetes, stroke, etc., are widely
available. The relationship between telomeres and CHD is well studied in the literatures
and results were mostly consistent across different study populations. A meta-analysis
and systematic review summarizing these results found that those with shorter telomeres
had higher risks of CHD [48]. Similar results were reported in another meta-analysis,
which reported a significant association of shorter telomeres with higher risks of stroke,
myocardial infarction, and type 2 diabetes mellitus [49].
Besides non-genetic observational studies, genetic studies also found that people with
a higher genetic risk score (GRS) of telomeres constructed using TL-associated variants
also had higher risk of CHD [22, 50]. The presumed causal effects of shorter telomeres on
CHD seemed to be insensitive to different study designs and populations. Regarding the
association between telomeres and stroke risk, more longitudinal studies are needed. A
recent Mendelian randomization (MR, method described in the Methods section 3.2.1)
study did not find a significant association of shorter telomeres with stroke risk [51].
As for diabetes, a MR study of TL reported no statistically significant association
between shorter telomeres and diabetes risk [52]. Sample size and lower power may be a
weakness of this study; however, further analysis using DIAGRAM Consortium data did
not show a significant association with diabetes, nor with other glycemic traits with the
exception for fasting insulin or insulin resistance [51]. This is an interesting finding and
deserves further investigation whether the finding could be replicated in future studies with
similar sample size and power.
1.4.2 Neurological Disorders
Several studies have reported a significant associations between telomeres and dementia.
The Washington Heights-Inwood Community Aging Project found that shortened leukocyte
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TL was associated with higher risks of incident dementia [53], similar to that observed
in the Medical Research Council-Cognitive Function After Stroke Study [54]. Our study
using a MR design and GWAS summary statistics data also obtained similar results [55].
Consistent with these findings, the association between telomeres and cognitive per-
formance were reported in several observational studies [56, 57], and a Mendelian ran-
domization collaboration study of telomeres and general cognitive ability also supported
this finding [58]. However, a recent longitudinal study with repeated measurements of
both telomeres and cognitive function found that TL changes did not predict changes in
cognitive and physical abilities [59].
Studies regarding telomeres and Parkinson’s diseases (PD) are much fewer and the
findings were inconsistent. A Japanese study did not find significantly shorter telomeres in
Parkinson’s patients [60]. Similar non-significant results were also reported in the Health
Professionals Follow-up Study [61]. A recent meta-analysis summarizing these studies
did not report a significant difference for telomeres between 956 PD patients and 1284
controls [62]. Studies of telomeres in relation to other neurological disorders are scarce. A
recent study reported shorter telomeres in patients with multiple sclerosis [63] and patients
with migraine [64].
1.4.3 Psychiatric Disorders
The relationship between telomeres and psychiatric disorders is much more complicated
than other diseases. A large case-control study reported longer telomeres in schizophrenia
patients compared with healthy controls [65], while others found the opposite [66, 67].
However, telomeres were reported to be shorter in those with depression as shown in recent
meta-analysis [68, 69].
1.4.4 Cancer
Long telomeres have been hypothesized as one of the main causes for infinite cancer cell
division for a long time. However, a recent study using genetically predicted telomeres
found the story between long and short telomeres and cancers may not be that simple as
expected [70]. This study involving five common cancers (prostate cancer, breast cancer,
lung cancer, ovarian cancer, and colorectal cancer) using summary data from 51 725 cases
and 62 035 controls found that longer telomeres were associated with increases in lung
adenocarcinoma risk, but not others [70].
In parallel, another recent comprehensive MR study reported that longer telomeres
may be associated with increased risks of colorectal cancer, breast cancer, serous invasive
ovarian, lung adenocarcinoma, bladder cancer, chronic lymphocytic leukemia, glioma, and
serious low-malignant-potential ovarian cancer; and decreased risks of testicular germ cell
cancer and prostate cancer, using a bigger GWAS summary statistics data (21 datasets)
[51].
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1.4.5 Mortality
The ultimate hypothesis in telomere research that attracts researchers for a life-long time
dedication to its study is to elaborate if we can elongate telomeres to extend our life-
span. The topic, telomeres and longevity in human being, is very captivating, but also
challenging.
Observational studies on telomeres and mortality may offer some clues. The most
cited research answering this question really observed some exciting results: people with
shorter telomeres had poorer survival, attributable in part to a 3.18-fold higher mortality
rate from heart disease and an 8.54-fold higher mortality rate from infectious disease in
Utah, USA [71]. However, the Leiden 85-plus Study did not replicate this finding [72],
nor did the Lothian Birth Cohort 1921 study [73] or the Zutphen Elderly Study [74].
The MacArthur Health Aging Study further showed that it was TL changes overtime,
not baseline telomeres, that could predict mortality [75]. The Bruneck Study in Italy
additionally found that shorter leukocyte telomeres were associated with cancer mortality
[76, 77]. Findings from the largest study on this topic to date, the Copenhagen City Heart
Study and the Copenhagen General Population Study [78], corroborated previous findings.
Two more recent studies suggested that these associations could differ by ethnicity [79,
80].
Moving Forward
This chapter has summarized some of the updated results, particularly from epidemiological
reports, on telomeres research. These studies have conveyed important and significant
information to research community as well as to public society, and played a critical role
in evidence synthesis and causal inference on telomeres. They, however, do have some
limitations, which could be addressed in future research. In the following chapters, we will
examine the role of telomeres in aging-associated diseases and traits and provide additional
evidence from new perspectives.

2. Aims
The overall aim of this thesis is to provide evidence for a better understanding of the role
of telomere length in the epidemiology of aging. More specifically, the aim of each study
is as follows:
I. To examine the causal effect of telomere length on Alzheimer’s disease using a
Mendelian Randomization approach and GWAS summary statistics.
II. To explore the potential causal pathways from telomere length to coronary heart
disease using a network Mendelian Randomization approach and GWAS summary
statistics.
III. To investigate the association of telomere length with general cognitive trajectories
using data from four cohorts.
IV. To study the association of telomere length with all-cause mortality using generalized
survival models.

3. Methods and Results
This chapter was organized as follows. We first described the data and cohorts as well as
the variables that were used for Study I-IV in section 3.1, then we introduced the statistical
analysis methods in section 3.2. Section 3.3 was presented for results in the order of the
four studies.
3.1 Data
3.1.1 GWAS Summary Statistics
The summary statistics were generated by genome-wide association studies, which are
observational studies investigating the associations of a set of genome-wide genetic variants
with specific traits (eg. telomere length). The publicly available GWAS summary statistics
typically focus on the associations of single-nucleotide polymorphisms (SNPs) and traits.
In this thesis, the following GWAS summary statistics were used.
Telomere Length GWAS
The telomere length GWAS was conducted by the European Network for Genetics and
Genomics Epidemiology (ENGAGE) Consortium [22]. This study consists of 37 684
individuals with replication of selected SNPs in an additional 10 739 individuals. All
participants were of European ancestry. Mean leukocyte telomere length was measured
by PCR-based technique in all samples. Details of genotyping methods, quality control
criteria, and analysis methods were described previously [22].
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Alzheimer’s Disease GWAS
The Alzheimer’s disease (AD) GWAS was performed by the International Genomics
of Alzheimer’s Project (IGAP) Consortium [81]. The study participants were also of
European ancestry. IGAP is a two-stage study, in which 7 million SNPs were meta-
analzyed from previously published GWAS datasets consisting of 17 008 AD cases and
37 154 controls in the first stage and 211 632 SNPs were genotyped and tested for the
association in an independent sample of 8 572 AD cases and 11 312 controls. Finally, a
meta-analysis was performed to combine results from stage 1 and stage 2 [81].
Coronary Heart Disease GWAS
CARDIoGRAMplusC4D (Coronary ARtery DIsease Genome wide Replication and Meta-
analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics) consortium
represents a collaborative effort to combine data from multiple large scale genetic studies
to identify risk loci for coronary artery disease and myocardial infarction. In this thesis, we
mainly used CARDIoGRAM GWAS summary statistics as our primary data for analysis
because other CARDIoGRAMplusC4D GWAS summary statistics were pooled from
studies of both European and South Asian descent, while CARDIoGRAM GWAS is a
meta-analysis of 22 GWAS studies of European descent imputed to HapMap 2 involving
22 233 cases and 64 762 controls [82].
Metabolic Biomarkers GWAS
MAGIC (the Meta-Analyses of Glucose and Insulin-related traits Consortium) represents
a collaborative effort to combine data from multiple GWAS to identify additional loci
that impact on glycemic and metabolic traits [83, 84]. The DIAGRAM (DIAbetes
Genetics Replication And Meta-analysis) consortium is a grouping of researchers with
shared interests in performing large-scale studies to characterise the genetic basis of
type 2 diabetes, and a principal focus on samples of European descent [85, 86]. The
Genetic Investigation of ANthropometric Traits (GIANT) consortium is an international
collaboration that seeks to identify genetic loci that modulate human body size and
shape, including height and measures of obesity [87]. Global Lipids Genetics Consortium
performed large-scale meta-analysis of blood lipid fractions (total cholesterol, low-density
lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride) [88]. Within
the ENGAGE Consortium, investigators undertook large-scale meta-analysis of GWAS
supplemented by 1000 Genomes imputation for eight quantitative (lipid, glycaemic and
obesity-related) traits in individuals of European ancestry [89, 90].
3.1.2 Cohorts
Swedish Twin Registry
The Swedish Twin Registry was established in the 1950s, and becomes one of the largest
twin registries in the world. The registry currently contains more than 190 000 twins
born between 1886 and 2008. Within the Swedish Twin Registry, several studies were
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conducted and are described below.
GENDER
The Sex Differences in Health and Aging (GENDER) is a population-based cohort study
from the Swedish Twin Registry and has recruited unlike-sexed twins born between 1906
and 1925 in Sweden [91]. Four hundred and ninety eight individuals of European ancestry
participated in the first in-person testing including cognitive tests, health examination, and
blood sample collection from 1995. In-person testing follow-up was conducted up to three
times on a four-year rolling interval during the years 1995 to 2005 with an average of 5.6
years (standard deviation [SD]: 2.0 years) follow up. In total, four hundred participants
had at least one cognitive test and 404 participants had TL assessed. The combined data
for TL and general cognitive ability were available for 327 participants.
SATSA
The Swedish Adoption/Twin Study of Aging (SATSA) is a population-based cohort study
from the Swedish Twin Registry. It was initiated in 1984 to study twin pairs reared apart
or reared together, and 859 individuals of European ancestry participated in at least one
wave of in-person testing [92, 93]. In the present study, 632 participants had at least one
cognitive assessment during the third, fifth, sixth, eighth, or ninth in-person testing, and
638 participants had telomere length measured. In total, 566 participants had both TL and
general cognitive ability assessed. Follow-up was conducted up to 5 times during years
1992 to 2012 with an average of 10.5 years (SD: 5.0 years) follow-up.
OCTO-Twin Study
The Origins of Variance in the Old-Old: Octogenarian Twins (OCTO-Twin) Study is a
longitudinal study of twins aged 80 years and over [94] from the Swedish Twin Registry.
The first data collection was conducted between 1991 and 1994. Blood samples were
collected during the second data collection wave. Twins who were not participants of
SATSA were eligible for this study. Blood samples for this study were collected between
1993 and 1996. For the present study, 366 twins born between 1900 and 1928 donated
blood samples during the years 1992 to 1996 and had TL measured; this sample has been
described previously.
MCSA
The Mayo Clinic Study of Aging (MCSA) is a prospective population-based study using
a stratified random sampling design that began in 2004 in Minnesota, US [95]. The
study population consisted of participants aged 50 years and above. In this study, 1267
participants had TL assessed and 1225 participants had at least one cognitive measurement.
The present analyses included 1205 participants primarily of European ancestry with
available data on both TL and at least one cognitive testing. Participants were followed up
at 15-monthly intervals for up to seven times from the year 2008 to 2017 with an average
of 3.9 years (SD: 1.6 years) follow-up.
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HRS
The Health and Retirement Study (HRS) is a nationally representative longitudinal survey
of more than 37000 individuals over the age of 50 years in 23000 households in the US.
The survey, which has been fielded every two years since 1992, was established to provide
a national resource for data on the changing health and economic circumstances associated
with aging at both individual and population levels. Details of HRS were described
elsewhere [96]. Cognitive ability was assessed up to four times in 20819 participants
during years 2008 to 2014 with an average of 5.0 years (SD: 1.5 years) follow-up. A
subset of participants (n=5808) had TL assessed. In the present study, we included 3857
participants of European ancestry who had data available on both TL and general cognitive
ability.
3.1.3 Measurements
Telomere Length
Telomere length was measured using PCR method in ENGAGE Telomere Consortium,
SATSA (Study III), GENDER, MCSA, and HRS, and using Southern blot in SATSA
(Study IV) and OCTO-Twin Study. The detailed experimental procedures can be found in
a previous article [22] and two manuscripts for Study III and IV.
General Cognitive Ability
In GENDER and SATSA, a general cognitive ability score based on performance on
cognitive tests was derived through the extraction of the first principal component analysis
of Synonyms, Block design, Thurstone Picture Memory, and Symbol Digit tests, exclud-
ing any prevalent dementia cases [97, 98]. The principal component analysis scoring
coefficients were applied from the baseline wave to the subsequent waves with subtests
z-transformed to their respective baseline means and standard deviations so that intra-
individual change could be assessed. For MCSA, a global cognitive z-score was calculated
using the z-score-transformed means of the four cognitive domain z-scores for memory,
language, executive function, and visuospatial skills domains [99]. For HRS, a total cogni-
tive score was constructed from immediate and delayed word recall, serials 7, backwards
counting from 20, and object naming and then z-transformed [100].
All-Cause Mortality
All-cause mortality (Study IV) data with exact dates of death were obtained through
linkages of Swedish Twin Registry to the Swedish Population Registry. The mortality data
used in this study were updated through November 15, 2017.
Covariates
Educational attainment (Study III) was the self-reported highest education. In GENDER,
it was classified as less than elementary school, elementary school, more than elementary
school, vocational school, high school, and university or higher. In SATSA, educational
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attainment was classified as elementary school, vocational school, high school, and uni-
versity or higher. Educational attainment was defined as the number of years in school
in MCSA, while it was defined as the highest degree of education that was classified as
no degree, general education development, high school diploma, two year college degree,
four year college degree, Master degree, professional degree (Ph.D., M.D., or J.D.), and
degree unknown/some college in HRS. Education Attainment was used as it was reported
and was not recoded further in the analyses.
3.2 Statistical Methods
3.2.1 Mendelian Randomization
Mendelian Randomization approach is one of causal inference techniques and adopted
from instrumental variable method commonly used in economics and sociology. This
approach aims to estimate the association of a variable (eg. exposure variable: TL) with
another (eg. outcome variable: CHD) by working with a third variable (eg. genetic variant)
as an instrument (named as instrumentalvariable) that is independent of the confounders
between the exposure and the outcome and avoids reverse causation [101, 102]. If no
other biases are present, then the MR estimates have a causal interpretation. MR analysis
has become a fashionable method for causal inference in medical research since the last
ten years. A quick PubMed search of the term "Mendelian Randomization" or "Mendelian
Randomisation" gives the following Figure 3.1.
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Figure 3.1: Number of Articles in PubMed
The MR approach is usually compared with RCT because it confers some benefits of
randomization. The following Figure 3.2 is usually presented to support this argument.
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Randomized Controlled Trial
Randomization by researcher
Control Treatment
Other factors equal
Compare outcome between groups
Mendelian Randomization
Randomization at conception
No effect allele Effect allele
Other factors equal
Compare outcome between groups
Figure 3.2: Comparision of Randomized Controlled Trial and Mendelian Randomization
The MR framework is illustrated in Figure 3.3. We are interested in testing and
estimating the association of TL with some outcome variables. Some measured and
unmeasured confounders could bias the results if not well controlled. Suppose we have a
genetic variant that only affects TL and there are no other variables other than those drawn
in Figure 3.3, then we can conclude that TL is a causal risk factor for the outcome if we
find that the genetic variant is also associated with our outcome variable, because the only
path that the genetic variant could affect the outcome must be through TL.
Genetic Variants Telomere Length Outcome
Confounders
Figure 3.3: Mendelian Randomization Framework
Three assumptions are essential for MR inference:
I. The Genetic variant (eg. SNP) has a causal effect on the exposure variable (eg. TL)
II. The Genetic variant (eg. SNP) affects the outcome (eg. AD) only through its potential
effect on the exposure variable (eg. TL)
III. The Genetic variant and the outcome do not have common causes.
These assumptions are sometimes referred to as the instrument relevance, exclusion
restriction, and unconfoundedness or independence conditions, respectively. The three
assumptions are sufficient to test if the exposure (eg. TL) is causally associated with the
outcome. The MR estimator will be introduced in Section 3.2.3.
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3.2.2 Network Mendelian Randomization
A Network Mendelian Randomization (NMR) extends the MR framework to explore the
pathway/mechanism/mediation in a larger system [103]. Figure 3.4 shows an example we
used to examine the potential causal pathways from TL to coronary heart disease (Study
II). It consists of three different MR tests that are all described below:
I. An MR analysis to determine the causal effect of TL on CHD using TL genetic risk
score (GRS) as instrumental variable.
II. MR analyses to examine the causal effects of TL on the metabolic biomarkers (eg.
insulin) using TL GRS as instrumental variable.
III. MR analyses to examine the causal effects of the possible mediators (eg. insulin) on
CHD using metabolic biomarker GRS as instrumental variable.
If causal associations are observed in all three steps, then a conclusion can be drawn that
the specific metabolic risk factor may lie in the causal pathway from TL to CHD.
Telomere GRS Telomere
Confounder
CHD
Insulin Insulin GRS
Figure 3.4: Network Mendelian Randomization
3.2.3 MR Using GWAS Summary Statistics
MR is an appealing approach to draw causal inference and does not need to measure
confounders (SNPs, exposure, outcome are sufficient in theory). However, it does require
a large sample size. Applying MR in practice thus becomes infeasible for empirical
epidemiologists because our sample sizes are usually not big enough for MR analysis. One
solution is to take advantage of the GWAS summary statistics data, which have offered a
unique opportunity to perform MR or NMR [104].
For a single genetic variant as the instrumental variable, the common MR estimator,
Wald ratio estimator can be used. It is essentially the ratio of association of the genetic
variant with the outcome (G−Y , e.g. SNP-CHD) and the association of the genetic variant
with the exposure (G−X , e.g. SNP-TL):
βiv =
βGY
βGX
(3.1)
where βiv is the MR estimate, βGY denotes the association of genetic variant with the
outcome, and βGX represents the association of genetic variant with the exposure. The
value of βGX can be found in published articles and that of βGY can be obtained from
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GWAS summary statistics data or from the authors of that GWAS article where the outcome
data are from.
When multiple genetic variants are available as the instrumental variables, special
methods are needed to combine these multiple genetic variants. The first and most
commonly used method is the inverse variance weighted approach [105], where the final
MR estimator is viewed as the weighted average of estimates from each variant:
βiv =
∑ni=1βGXβGYσ
−2
GY
∑ni=1β 2GXσ
−2
GY
(3.2)
where βiv is the MR estimate, βGY and σGY denote the association of the genetic variant
with the outcome and standard error, and βGX represents the association of the genetic
variant with the exposure.
Other estimators, such as MR-Egger regression and weighted median method are also
available for MR inference, and can be used as the alternative methods for sensitivity
analysis [106, 107]. We did not use them here in this thesis.
3.2.4 Latent Growth Curve Models
Latent growth curve models were developed to model repeatedly measured variables. These
models can be fitted via both structural equation modelling approaches and multilevel
modelling methods [108]. They are also referred to as mixed models or random coefficients
models, which are common in medical literature. In this thesis (Study III), we used the
random effects model and attained age was centered. A couple of models were fitted and
compared in Study III.
The basic random intercept and slope model to assess the association of TL with the
mean levels of general cognitive ability is specified as:
yi j = β0 +u0i +(β1 +u1i)agei j +β2xi +β3sexi + εi j (3.3)
where i represents the individual and j is the measurement occasion, x and y denote
telomere length and general cognitive ability, u0i and u1i are random intercepts and slopes,
respectively, and they follow
[u0i
u1i
]∼MV N([00],[ σ21 σ12σ12 σ22 ]), the random error term εi j ∼
N(0,σ2).
To examine the association of TL with the decline of general cognitive ability, the
following model is specified as:
yi j = β0 +u0i +(β1 +u1i)agei j +β2xi +β3sexi +β4xiagei j + εi j (3.4)
where i represents the individual and j is the measurement occasion, x and y denote
telomere length and general cognitive ability, u0i and u1i are random intercepts and slopes,
respectively, and they follow
[u0i
u1i
]∼MV N([00],[ σ21 σ12σ12 σ22 ]), the random error term εi j ∼
N(0,σ2).
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3.2.5 Generalized Survival Models
Generalized survival models (GSM) were developed for survival data analysis [109, 110].
It has the advantage of estimating the baseline hazard and effect measurements in a more
flexible and elegant fashion. It can be easily extended to accommodate the between-within
twin decomposition, which allow us to control for unmeasured shared confounders for
twins within the same twin-pair [111, 112]. In this thesis (Study IV), we used the between-
within twin shared frailty model in the GSM framework to study the association of TL
with all-cause mortality.
For the thesis, the between-within shared frailty model in the GSM framework was
specified with a log-log link function. For a time-constant effect, the model was specified
as:
log
(
− log(S(ti j|xi j,ui j)))= log(ui j)+β1sexi +βBx¯i +βW xi j + s0(ti j;γ) (3.5)
where i represents the twin-pair, j is the individual twin, the frailty term ui is assumed
to follow a gamma distribution, xi j denotes TL for each individual, βB is the between
twin-pair effect, x¯i is the mean TL in each twin-pair, βW is the within twin-pair effect, and
s0(ti j;γ) is a smooth function representing the transformed baseline survival function. This
model with a log-log transformation of survival is interpreted as a proportional hazards
model. For time-dependent hazard ratios, the model was specified as:
log
(
− log(S(ti j|xi j,ui j)))= log(ui j)+β1sexi +βBx¯i + xi js1(ti j;βW )+ s0(ti j;γ) (3.6)
where s1(ti j;βW ) is a smooth function representing the time-dependent within twin-
pair effect and where βW is now a vector of parameters. The smooth parameters were
modeled as natural splines with 2 degrees of freedom for baseline survival and 1 degree of
freedom for the time-dependent hazard ratio; the degrees of freedom were selected using
AIC and the associations were robust to the choice of degrees of freedom. The models
were fitted using maximum marginal likelihood estimation, with suitable adjustment for
left-truncation under a shared frailty model [113]. We compared models with and without
the time-dependent effects using a likelihood ratio test. We also assessed whether the effect
of TL was linear by including the natural spline term for TL in the time-constant model
and compared the models with a likelihood ratio test. The within effect, βW is what we are
interested in.
3.2.6 Statistical Packages
All analyses were conducted using SAS 9.4 (SAS Institute, Cary NC) and R 3.4 [114].
Meta-analysis was performed using the rmeta package [115]. Heterogeneity test was
conducted in the gtx package [116]. Figures were plotted using the ggplot2 package [117].
The GSMs were implemented in the rstpm2 package [118].
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3.3 Results
This section is organized as follows. Study I and Study II used similar methods and are
presented first. The results for Study I is described in Section 3.3.1, and those for Study II
are delineated in sections 3.3.2, 3.3.3, and 3.3.4. Section 3.3.5 is for Study III, and the
last section 3.3.6 is presented for Study IV.
In Study I and Study II, we selected seven SNPs (rs10936599, rs2736100, rs7675998,
rs9420907, rs8105767, rs755107, and rs11125529) which are of genome-wide significance
for TL as instrumental variables. These SNPs are located or near to TERC, TERT, NAF1,
OBFC1, ZNF208, RTEL1, ACYP2. They are identified from a previous GWAS of TL in
the ENGAGE Telomere Consortium [22]. Theses SNPs and their associated effect sizes on
TL are listed in Table 3.1.
SNPs Gene Risk Allele β (se)
rs10936599 TERC T −0.097(0.008)
rs2736100 TERT A −0.078(0.009)
rs7675998 NAF1 A −0.074(0.009)
rs9420907 OBFC1 A −0.069(0.010)
rs8105767 ZNF208 A −0.048(0.008)
rs755017 RTEL1 A −0.062(0.011)
rs11125529 ACYP2 C −0.056(0.010)
Table 3.1: Selected SNPs for Telomere Length and Effect Sizes
3.3.1 Telomere Length and Alzheimer’s Disease
In study I, we examined whether TL was associated with Alzheimer’s disease by applying
MR approach to the GWAS summary statistics for Alzheimer’s disease from the IGAP
Consortium [55, 81]. We extracted the effect sizes and associated standard errors for the
seven SNPs as listed in Table 3.1 from the IGAP Consortium, and then harmonized them
to align the effect alleles to be the same for both TL and AD. We applied inverse-variance
weighting approach for the MR analysis.
By combining the seven SNPs shown in Table 3.1 as the instrumental variables, the
MR analysis showed that one standard deviation (SD) decrease of TL was associated
with higher odds of AD (odds ratio: 1.36, 95% confidence interval: 1.12-1.67). We also
performed the heterogeneity test, which did not show a significant heterogeneous effects
among the seven SNPs (P = 0.29). These SNPs and their associated effects on AD and TL
were visually plotted in Figure 3.5.
3.3 Results 21
−0.10 −0.08 −0.06 −0.04 −0.02 0.00−0.10
−0.05
0.00
0.05
0.10
Effects of SNPs on Telomere Length, βE
ff
ec
ts
of
SN
Ps
on
A
lz
he
im
er
’s
D
is
ea
se
,l
og
(O
dd
s
R
at
io
)
Figure 3.5: Plot of the Effect Sizes of SNPs on Telomere Length and Alzheimer’s Disease. The
slope of solid line denotes the effect of one SD increase of TL on AD: log(odds ratio) and those of
dashed lines represent 95% confidence intervals.
3.3.2 Telomere Length and Coronary Heart Disease
Study II aimed to explore the potential causal pathway from shorter TL to CHD using the
network MR approach. In the first step, we replicated previous findings which reported that
shorter TL was a causal risk factor for CHD from the MR perspective. The MR analysis
using the same seven SNPs shown above as the instrumental variables showed one SD
decrease of TL was associated with 1.26 (95% CI:1.03, 1.54) higher odds of CHD in the
CARDIoGRAM Consortium. The effects of these SNPs on CHD were described in Table
3.2 and Figure 3.6. A previous analysis oriented from the genetic risk score analysis was
performed in the ENGAGE Telomere Consortium. Our result is similar to that reported.
SNPs Gene Risk Allele log(OR),se
rs10936599 TERC T 0.026(0.016)
rs2736100 TERT A 0.021(0.017)
rs7675998 NAF1 A −0.025(0.017)
rs9420907 OBFC1 A 0.058(0.021)
rs8105767 ZNF208 A 0.019(0.016)
rs755017 RTEL1 A 0.004(0.023)
rs11125529 ACYP2 C 0.020(0.019)
Table 3.2: Association of SNPs for Telomere Length with Coronary Heart Disease.
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Figure 3.6: Plot of the Effect Sizes of SNPs on Telomere Length and Coronary Heart Disease. The
slope of solid line denotes the effects of one SD increase of TL on CHD: log(odds ratio) and those
of dashed lines represent 95% confidence intervals.
3.3.3 Telomere Length and Metabolic Biomarkers
The MR estimates of TL with metabolic biomarkers are presented in Table 3.3. These
biomarkers include fasting insulin, triglycerides, total cholesterol, low-density lipoprotein,
fasting glucose, diabetes mellitus, HbA1c, body mass index, waist circumference, and
waist to hip ratio. Because several large GWAS summary statistics data from different
consortia were available for the same biomarker, we used the earlier and largest GWAS
summary statistics as the discovery data and the most recent data as the replication data.
Our MR analyses showed that TL was associated with fasting insulin and lipid fractions
in the discovery phase. However, only the result for fasting insulin was replicated in the
replication phase. One SD increase of TL was associated with −0.07 unit decrease of
fasting insulin.
3.3.4 Insulin and Coronary Heart Disease
Based on the previous MR examination of TL with metabolic biomarkers, fasting insulin
was suggestive of being a potential mediator from shorter TL to increased risk of CHD.
Thus, we further evaluated whether insulin was associated with CHD using MR analysis.
We used 12 SNPs that were reported by the MAGIC Consortium to be associated with
fasting insulin as the instrumental variables (Figure 3.4). We found one unit increase
of log-transformed fasting insulin levels was associated with higher odds of CHD (OR:
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Metabolic Biomarkers β se
Discovery
Fasting Insulin −0.0679 0.027
TG 0.0796 0.027
LDL 0.0746 0.030
TC 0.0702 0.029
Fasting Glucose 0.0236 0.026
Diabetes −0.1205 0.122
HbA1c 0.0018 0.023
BMI −0.0005 0.023
WC 0.026 0.027
WHR 0.050 0.026
Replication
Fasting Insulin −0.0806 0.029
TG 0.0386 0.039
LDL 0.0736 0.039
TC 0.0453 0.039
WHR 0.014 0.041
Table 3.3: MR Estimates for the Association of Telomere Length with Metabolic Risk Factors for
Coronary Heart Disease. TG: triglyceride, LDL: low density lipoprotein, TC: total cholesterol,
BMI: body mass index, WC: waist circumference, WHR: waist to hip ratio.
2.61, 95% CI:1.55-4.48). Because rs1421085 is located in the FTO locus and potentially
pleiotropic, it was excluded further. Analysis of the remaining SNPs yielded an effect size
of 2.41 (95% CI: 1.31-4.26). Additionally excluding rs2972143 in IRS−1 revealed an OR
of 1.86 (95% CI: 1.01-3.41).
Hence, based on these analyses above, we found that TL was a causal risk factor for
CHD in the first step, and was a causal risk factor for insulin which was further a causal
risk factor for CHD. Taken together, these analyses suggest fasting insulin might act as a
mediator in the causal pathway from shorter TL to CHD.
3.3.5 Telomere Length and General Cognitive Ability
In Study III, we applied the latent growth curve models to data from 5955 participants of
two Swedish cohorts (GENDER and SATSA) and two US cohorts (MCSA and HRS), and
found that one SD increase of TL was associated with 0.021 unit increase of standardized
mean general cognitive ability (95% CI: 0.001,0.042) after adjusting for attained age. The
point estimate remained similar (0.019) but with wider confidence intervals (95%: −0.002,
0.039) after further adjusting for sex. The association was attenuated with additional
adjustment for educational attainment, depression, and coronary heart disease. We did
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SNPs Gene Risk Allele log(OR),se
rs2820436 LYPLAL1 C 0.023(0.015)
rs1530559 YSK4 A 0.012(0.020)
rs10195252 GRB14 T 0.014(0.014)
rs2972143 IRS1 A 0.052(0.014)
rs9884482 TET2 C 0.018(0.015)
rs4865796 ARL15 A 0.034(0.014)
rs2745353 RSPO3 T 0.003(0.014)
rs1167800 HIP1 A 0.027(0.016)
rs983309 PPP1R3B T −0.031(0.024)
rs7903146 TCF7L2 C −0.019(0.015)
rs1421085 FTO C 0.031(0.015)
rs731839 PEPD G 0.021(0.016)
Table 3.4: Association of 12 SNPs for Insulin with Coronary Heart Disease.
not find strong evidence for the association of TL with decline (i.e. the slope) of general
cognitive ability (β = 0.002, 95% CI: −0.002, 0.004).
3.3.6 Telomere Length and All-Cause Mortality
In Study IV, we applied the between-within shared frailty model to the twin data (SATSA
and OCTO-Twin). Of the 366 twins, 115(31.4%) were men and 251 (68.6%) were women.
The mean ages of the participants at blood drawn were 76.5 years for men and 80.3 for
women. Follow-up duration spanned from ten days to 25.7 years (mean: 10.2 years).
During the follow-up period, 341(93.2%) participants died.
We found that shorter TL was associated with higher mortality rate in general (within
twin-pair effect). Assuming a time-constant within effect, the estimated hazard ratio for
a 0.5 kbp reduction in TL was 1.18(95% CI: 1.00, 1.38). We did not find evidence for
a non-linear effects of TL on all-cause mortality (likelihood ratio test, P = 0.32). There
was, however, strong evidence that this association was not time-independent (likelihood
ratio test, P = 0.001). The time-dependent hazard ratios approached 1 with increasing age,
whereas the point-wise hazard ratios were not statistically significant at around 90 years
old (Figure 3.7). We also performed additional analyses to examine if results differed
by sex, zygosity, or varying degrees of freedom of the smooth function. These analyses,
however, yielded similar results.
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Figure 3.7: Association of Telomere Length with All-Cause Mortality. The solid line represents the
hazard ratio for 0.5 kbp (kilo base pairs) decrease, and the grey shade denotes the point-wise 95%
confidence intervals. The rug on the x-axis represent the event times

4. Discussion and Conclusion
The work in this thesis has examined the associations of leukocyte telomere length with
several outcomes including coronary heart disease, metabolic biomarkers, Alzheimer’s
disease, general cognitive ability, and all-cause mortality, which are among the most
commonly studied traits in epidemiological research on aging. We found that telomere
length was associated with coronary heart disease, Alzheimer’s disease, and all-cause
mortality, but not with general cognitive ability. Furthermore, we found that insulin might
mediate the association of telomere length with coronary heart disease. These findings
added new evidence in the literature of the short and long story of telomeres.
4.1 General Discussion
4.1.1 Implications
The four studies in this thesis highlight the importance of telomeres in the etiology of
aging-related diseases and traits, specially CHD, insulin, AD, and mortality. These findings
largely corroborate previous results of the same topics. However, our studies examined
the role of telomeres in aging from novel perspectives. In Study I and II, we applied MR
method, the results from which are independent of measured and unmeasured confounding
and reverse causation. In Study III, we used longitudinal data, while in Study IV we
exploited twin data. If the modelling assumptions hold and no other biases are present,
then shorter telomeres are causes of CHD, insulin, and AD. However, the potential roles of
telomeres in clinical setting or drug development are beyond the scope of this thesis. The
following discussions might serve as an introduction to the unanswered questions.
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4.1.2 Telomere Length Measurement Error
As repeated sequence of nucleotides, telomeres are difficult to measure in large-scale
epidemiological studies. Measurement error challenges the validity of epidemiological
research and makes comparison of results across different studies troublesome.
In Study I and II, we only used the TL−associated SNPs as proxies for TL, and did not
have the physically measured TL. Using TL−SNPs as instrumental variables can minimize
the impact of its measurement error (non-differential). This is one of the advantages in MR
analysis [119]. In the ENGAGE Telomere Consortium, the measurement error in TL does
not affect the final estimates (effect sizes: β s) but affects the associated standard errors.
Fortunately, the sample size in ENGAGE Telomere Consortium is large, and thus these
standard errors of the selected top SNPs are small. We thus could assume that the effect
sizes of these SNPs are valid. We then used these SNPs (with β s) in the MR analyses
followed.
In Study III and IV, we used the measured TL as the exposure variable and examined
its association with general cognitive ability and all-cause mortality. In these scenarios,
measurement error of TL does affect the estimates of these associations. The observed
association is generally underestimated and depends on the proportion of the true variance
explained by the observed variance of measured TL.
4.1.3 Mendelian Randomization Assumptions
The validity of MR inference relies on the three core assumptions. Assumption I, instrument
relevance, can be empirically tested by examining the associations of SNPs with TL.
Assumption II, unconfoundedness or independence, is assumed to hold by the nature
of Mendelian’s law (population stratification may still be a confounder which has been
adjusted for in the GWAS analysis, thus this could be called as conditional independence).
The main concern in MR literature centers on Assumption III, exclusion restriction, which
says that the effects of SNPs on the outcome are totally through the exposure (TL) or
these SNPs have no pleiotropic effects on other traits. Assumption III cannot be tested
empirically.
Besides the three core MR assumptions, additional assumption is necessary for the
analysis using GWAS summary statistics. The estimates of SNPs’ effects on the exposure
(TL) and on the outcomes are from different GWAS consortia, these different study
populations are assumed to be representative of the same underlying general population
(European ancestry in this thesis). Otherwise, the MR results are biologically impossible
and may not make sense.
In the MR literature, a lot of efforts have been made to improve the analysis, particularly
when Assumption III could be violated. The MR-Egger regression was developed to test
the pleiotropy and to correct for it by adding an intercept term in the weighted linear
regression models [106]. This approach is usually underpowered and taken as a sensitivity
analysis in practice. Other approaches include weighted median method [107], robust
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adjusted profile score method [120], etc.
In Study I and II, we did not use these alternative methods. One reason is that these
alternative methods are underpowered. A wide confidence interval does not help much in
achieving our primary aims. Another reason is the number of SNPs we used in Study I and
II is small for these methods. Our view is that a sufficient number of SNPs were necessary
for these methods. Unfortunately, we did not find an article discussing the number of
SNPs in MR analysis by the time of conducting Study I and II. Our results relied on the
inverse-variance weighting method.
The selection of SNPs for MR analysis was based on genome-wide significance levels.
This selection method is common in MR practice, particularly when the mechanisms of
these SNPs with TL are generally unknown. Selected SNPs with unknown function based
on this selection method are prone to pleiotropy. However, some of these selected SNPs
in this thesis are located in TERC, TERT, RTEL1, NAF1, and OBFC1 genes, which are
involved in telomerase or telomere biology [22]. The potential biological function with
these SNPs lays foundation to justify the validity of these SNPs.
One of the advantages of MR analysis is that the investigators do not need to measure
the confounders between the exposure and the outcome. This advantage is such appealing
that sometimes the investigators do not even think about what the potential confounders
could be. Which confounder or confounders do we want to control for but cannot do so and
then turn to MR approach to achieve this due to various reasons? In our study, we would
like to control for the inflammatory biomarkers and familial confounding that cannot be
sufficiently adjusted for in empirical analysis using cohort data.
MR analysis using summary statistics is a brilliant initiative to maximize the utility of
GWAS results. However, the secondary analysis of these GWAS summary statistics comes
with cost. Due to the limitations, the MR analysis should not be over-interpreted in practice.
It can be used primarily for testing purpose in which the associations between SNP and
the outcome could be tested in the first place. If a significant finding is observed, then it
is possible that the genetically determined exposure or the exposure per se is associated
with the outcome. If a null finding is obtained, then it is less possible that the exposure is
associated with the outcome. In general, a null finding is more plausible than a significant
finding if sample size and statistical power are not concerns [121].
4.1.4 General Cognitive Ability
A previous MR study using the same seven SNPs as instrumental variables examined TL
and its association with cognitive performance and found that shorter TL was associated
with lower levels of general cognitive performance [58]. In the same study, however,
the observational analysis did not find a significant association, which was similar to our
results. The reasons may lie in the fact that in both these studies, telomeres were measured
using PCR that was prone to measurement error as discussed previously. Another reason
might be that the true magnitude of the association of TL with general cognitive ability
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is indeed small. Taken together, estimating a small effect size with an exposure variable
measured with error requires a large sample size.
4.1.5 All-Cause Mortality
The relationship between TL with all-cause mortality has been examined extensively in
the literature. Most of the studies found shorter telomeres to be associated with higher
mortality rate, while a few others did not observe this association. The differences in
study population, telomere measurement methods, and variables controlled in the design
or analysis could account for the heterogeneity of results.
Although a number of confounders have been adjusted for in previous studies, residual
confounding such as family background or genetics could still bias these results. An elegant
way to control for shared familial confounding is to exploit the twin data, in which the
twin-pairs share familial characteristics. By controlling for the familial confounding and
using the between-within twin design and generalized survival models, we still observed
time-dependent association of TL with mortality rate. Taken together, these findings
indicate that the association of TL with all-cause mortality were independent of these
potential confounders.
4.2 Strengths and Limitations
4.2.1 Strengths
Studies compiled in this thesis provided valuable knowledge in the telomere research
literature, particularly for the aging epidemiology community. These studies are based on
novel statistical methods, the GWAS summary statistics data, and individual-level data of
good quality.
The MR approach allows us to examine the causal effects of TL on a number of
outcomes, while the GWAS summary statistics data are created from large collaboration
cohorts and offer a unique opportunity to apply the MR method. Besides that, the GWAS
summary statistics also provide us with an alternative resource to elaborate the pathways,
especially from a biomarker to a disease. In our study, the biomarker is telomere length.
The biomarker could also be other variables, such as educational attainment, which is of
greater interest for social scientists.
In Study III, we obtained data from repeated measurements of general cognitive ability
up to seven occasions. One advantage of longitudinal data is that they could be used to
examine the trajectory of a continuous variable and associated factors with its decline. In
this study, we did not find a strong evidence to support TL to be associated with cognitive
decline, while the magnitude of the association of TL with mean general cognitive ability
was small.
In Study IV, telomere length was measured using Southern blot method, which is
regarded as the gold standard for telomere length assessment. Then Southern blot method
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is costly and requires large amount of DNA. There are fewer epidemiological studies using
Southern blot than that using the PCR method. Telomere length reported in absolute length
(number of base pairs of nucleotides) has facilitated the interpretation of final estimates.
Besides that, the relatively more accurate measurements could minimize bias.
The application of between-within twin study using the generalized survival models
is novel. Confounding control is one of the central topics in epidemiology and other
quantitative disciplines. Many other techniques are also available for confounding control.
The successful application of the between-within model in Study IV allows us to examine
the relationship of two variables from a new perspective. Taking into account of previous
findings using different analytic methods on this topic, we are more confident about the
relationship between TL and all-cause mortality when a variety of methods pointed to the
same conclusion.
4.2.2 Limitations
Study I and II used MR approach, the data are from the GWAS summary statistics. Be-
sides the MR assumptions, some other limitations should be acknowledged. Because the
individual-level data are unavailable, more analyses cannot be performed. We cannot ex-
amine the gene-environment interaction, the non-linear relationship, nor stratified analyses
(for example, by sex, which is a common interest in medical research).
In addition to the measurement error for TL in Study III, general cognitive ability
was defined differently among the four cohorts. Measuring general cognitive ability in a
consistent and detailed way could definitely empower the inference. However, to the best
of our knowledge, even both TL and cognitive function are to be measured without error,
their association are not expected to be large. In this study, only a limited covariates were
considered as confounders and adjusted for. However, due to the null findings and small
magnitude of the associations, additional adjustment for other covariates could hardly
change the results or conclusions.
Study populations in this thesis are the elderly, particularly in Study IV where the
entry age of these participants were around 80 years old. Although the primary aim of
this thesis is examining telomere length in aging from the epidemiological perspective, it
is very interesting to revisit these analyses in a younger population from the life course
perspective.
Another common limitation to most epidemiological studies for telomeres is that
telomeres are measured as the average across all chromosomes within a cell and a mixture
of leukocytes including neutrophils, lymphocytes, and monocytes, etc. Thus, it is not quite
clear which telomeres are affecting the outcome. This concern can be alleviated if we use
TL-associated SNPs as proxies, assume these different telomeres are highly correlated,
and are interested in telomeres in general. However, more accurate measurement of
TL in different cells and chromosomes may provide further insights into the biological
mechanisms of telomeres in the aging process.
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4.3 Future Perspectives
The consequences of telomere shortening in human beings still need to be investigated.
Increasing knowledge about the genetics of telomeres has resulted in valuable insights
into telomere biology and its related diseases. However, the known telomere genes only
account for a small proportion of total variance in telomere length. In addition to that,
whether leukocyte telomere length reflects global or tissue specific telomere length still
deserves to be examined. Although exciting results were observed for the association of
leukocyte telomeres with many diseases, questions remain to be answered regarding if
it is leukocyte telomeres per se or together with tissue specific telomeres that contribute
to the disease development. Besides these etiological examinations, additional studies
looking at the diagnostic or prognostic performance of telomeres (regardless of leukocyte
or tissue-specific) may also be interesting from the clinical perspective in the near future.
The causes and trajectories of telomere shortening are not studied in this thesis. Due
to current limitations in telomere measurement, alternative methods (such as Mendelian
randomization using GWAS summary statistics) could provide valuable insights into the
causation of telomere shortening as well as examining if telomeres are involved in the
pathway from the variable of interest (eg. smoking) and the outcome of interest (eg.
coronary heart disease). Longitudinal studies with repeated measurements of telomeres
could also shed light on telomere dynamics. These investigations are definitely essential
for the completion of the short and long story of telomeres.
4.4 A Note on Causal Inference
Causal inference is one of the central tasks that modern epidemiology aims to complete.
We, epidemiologist, are eager to hunt and hopefully find some factor(s) that can cause
some diseases. We also know, even not trained in school, that a correlation between
two variables is true in that it correctly reflects these two are associated, but does not
necessarily mean one causes the other. Anaxagoras, an pre-Socratic Greek philosopher,
said All things were together, infinite both in number and in smallness. However, a
correlation or association between two variables is usually not what we are interested in,
how they are associated/connected is. Are they associated because of something else or
because one causes another? If something else, a third factor or a set of factors, might
causes both X and Y , the influence of the third factor(s) should be eliminated. This is
confounding control that has been being practiced all the time in epidemiology.
Many techniques are available to control confounding, such as randomization in the
study design stage or adjustment in the analysis stage. MR and within-between analyses are
also two of them to achieve this. Usually we reply on regression models with assumptions
that these variables are sufficient to control for confounding and the models are correctly
specified. Indeed, if this is the true data-generating mechanism and a significant association
is observed, a causal conclusion can be drawn. However, we tend not to do so or even not
4.5 Concluding Remarks 33
to use the word causal in our papers. Why? We know the assumptions are probably not
satisfied: residual confounding is a concern in most scenarios; the reviewers, editors, and
other researchers also know this and criticize more. Then a question naturally comes: how
can we conclude causal in practice?
Besides randomized controlled trials, causal inference from observational studies, in
my view, first requires replication. Replicating previous findings in the same underlying
population using the same design and analytic methods is necessary. Then replicate
them in different populations, and/or using different designs and/or different analytic
approaches. For example, the research questions in this thesis, are shorter telomeres
(causally) associated with aging-associated diseases and traits (AD, CHD, general cognitive
ability, and mortality), were addressed previously in different settings. We have now
examined them using novel approaches and from different perspectives. Taking all these
evidence together could definitely result in more robust insights in causal inference.
4.5 Concluding Remarks
The telomere story could be longer, but the thesis is short. In this thesis, several novel
analytical methods that have covered Mendelian randomization, latent growth curve models,
between-within twin study, and generalized survival models were applied to evaluate the
role of telomeres in aging. The four pieces of studies found shorter TL was generally
associated with worse health outcomes.
New evidence supporting shorter telomere length with higher odds of Alzheimer’s
disease were presented, novel mechanisms for shorter TL and coronary heart disease
were proposed, and the fundamental interest of TL shortening and all-cause mortality was
revisited from new perspectives. These findings deserved to be replicated in different and
new settings, such as non-European populations. Although we did not find strong evidence
underpinning the relationship of telomeres and general cognitive ability, further studies
with better measurements are warranted. In particular, telomere length measurement
techniques deserve to be improved and tailored for aging epidemiological research.
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